Fidji Simo
Coverage of Fidji Simo in the Nexus archive.
- OpenAI power consolidates under co-founder Greg Brockman ahead of prospective IPO
Fidji Simo left OpenAI due to a chronic medical issue, leading to Greg Brockman's clearer role as power consolidates under him ahead of a potential IPO.
- POTS explained: The disorder that led OpenAI exec Fidji Simo to step down
Fidji Simo, applications CEO at OpenAI, is stepping down from her full-time role to become a part-time advisor due to postural tachycardia syndrome (POTS), a chronic illness she has managed since 2019. Simo took medical leave in April after a severe exacerbation of her condition, which causes symptoms like heart palpitations and fainting.
- OpenAI's no. 2 exec, Fidji Simo, steps down for health reasons
Fidji Simo, the number 2 executive at OpenAI, has stepped down from her full-time role for health reasons and will transition to a part-time advisory role. She announced the decision in a post on X, formerly Twitter.
- Fidji Simo says Mark Zuckerberg gave her one piece of health advice years ago, and she wishes she had listened
Fidji Simo, an OpenAI executive, stepped down from her full-time role due to a chronic illness called POTS. She revealed that Mark Zuckerberg had advised her to take a year off years earlier, but she declined. Simo now regrets not heeding his advice and will transition to a part-time advisory role at OpenAI.
- OpenAI's product chief is stepping down after a chronic illness derailed her recovery
Fidji Simo, OpenAI's product chief and Sam Altman's second in command, is stepping down and becoming a part-time advisor due to her worsening POTS condition.
- OpenAI's No. 2 executive steps down over health issues
Fidji Simo is stepping down as OpenAI's head of product and business due to a worsening chronic illness. She went on medical leave in April, and OpenAI President Greg Brockman assumed her responsibilities during her absence. Simo will remain at OpenAI as a part-time advisor.
- OpenAI exec Fidji Simo says she's stepping down due to chronic illness, will transition to advisor
Fidji Simo is stepping down from OpenAI due to a chronic illness and will transition to an advisor role. She took medical leave in April to focus on recovery.
- Fidji Simo steps down from OpenAI’s no. 2 role
Fidji Simo, OpenAI's No. 2 executive, is stepping down from her full-time role due to an extended medical leave. Her departure creates a leadership vacuum as OpenAI considers an IPO and competes with Anthropic in the enterprise market.
- Fidji Simo steps down from leading OpenAI’s AGI work due to illness
Fidji Simo is leaving her full-time role as OpenAI's AGI chief and transitioning to a part-time advisor due to a neuroimmune condition. Around the same time, COO Brad Lightcap and CMO Kate Rouch also stepped down, with Rouch citing health reasons and planning to return to a more narrowly scoped role.
- Top OpenAI executive Fidji Simo is stepping down
Fidji Simo is stepping down from her role as CEO of applications at OpenAI after medical leave due to a chronic illness. She will transition to a part-time advisor role while focusing on her recovery.
- OpenAI’s CEO of AGI Deployment, Fidji Simo, Is Stepping Down
Fidji Simo, OpenAI’s CEO of AGI Deployment, is stepping down after taking significant medical leave. She will remain with the organization as a part-time adviser.
- OpenAI keeps shuffling its executives in bid to win AI agent battle
OpenAI is reorganizing its structure to focus on AI agents, with Greg Brockman leading product development. The company aims to create a unified AI agent platform by merging ChatGPT and Codex. This change follows recent leadership adjustments, including AGI boss Fidji Simo's medical leave.